Iradimed (IRMD) Operating Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,366.00 |
| Dec 31, 2025 | -6,534.00 |
| Sep 30, 2025 | 2,204.00 |
| Jun 30, 2025 | 7,637.00 |
| Mar 31, 2025 | 1,934.00 |
| Dec 31, 2024 | 936.00 |
| Sep 30, 2024 | 631.00 |
| Jun 30, 2024 | 563.00 |
| Mar 31, 2024 | 904.00 |
| Dec 31, 2023 | 807.00 |
| Sep 30, 2023 | 1,676.00 |
| Jun 30, 2023 | 805.00 |
| Mar 31, 2023 | 1,060.00 |
| Dec 31, 2022 | 1,371.00 |
| Sep 30, 2022 | 2,738.00 |
| Jun 30, 2022 | 2,682.00 |
| Mar 31, 2022 | 2,960.00 |
| Dec 31, 2021 | 106.00 |
| Sep 30, 2021 | -550.00 |
| Jun 30, 2021 | -1,505.00 |
| Mar 31, 2021 | -1,957.00 |
| Dec 31, 2020 | -3,048.00 |
| Sep 30, 2020 | -2,890.00 |
| Jun 30, 2020 | -7,851.00 |
| Mar 31, 2020 | -2,389.00 |
| Dec 31, 2019 | 1,427.00 |
| Sep 30, 2019 | 1,462.00 |
| Jun 30, 2019 | -850.00 |
| Mar 31, 2019 | -522.00 |
| Dec 31, 2018 | 59.00 |
| Sep 30, 2018 | 467.00 |
| Jun 30, 2018 | -538.00 |